Preoperative Antibiotics for Carpal Tunnel Release Surgery

NCT03432858 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2021-11-10

Study results available
· View outcomes & findings →

Summary

This is a clinical trial to determine how effective antibiotics administered prior to endoscopic carpal tunnel release surgery are in preventing surgical site infections.

Conditions

  • Carpal Tunnel Syndrome

Interventions

DRUG

Vancomycin

Vancomycin - 1-gram dosing

DRUG

Cefazolin

2-gram dosing for patients \<120 kg 3-gram dosing for patients 120 kg or greater

DRUG

Saline Solution

Placebo

Sponsors & Collaborators

  • WellSpan Health

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-05-17
Primary Completion
2020-12-14
Completion
2020-12-14
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03432858 on ClinicalTrials.gov